Barclays Starts Idenix Pharmaceuticals (IDIX) at Equalweight
Tweet
Share
E-mailGet Alerts IDIX Hot Sheet
Price: $24.50 --0%
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Barclays initiates coverage on Idenix Pharmaceuticals (NASDAQ: IDIX) with a Equalweight. PT $10.00.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $11.13 yesterday.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $11.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
